HBIO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Harvard Bioscience Inc

Watchlist Manager

Watchlist

Price: 8.15 USD 2.52% Market Closed

Market Cap: $36.8m

	Harvard Bioscience Inc NASDAQ:HBIO	US
M	MGIC Investment Corp SWB:MGC	US
L	Life Storage Inc F:SOV	US
	Rimini Street Inc NASDAQ:RMNI	US
E	Eli Lilly and Co XMUN:LLY	US
	Innovatec SpA F:5JT	IT
I	Isetan Mitsukoshi Holdings Ltd XBER:4HP	JP

Profitability Summary

Harvard Bioscience Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

58%

Strong 3Y Average Gross Margin

58%

Gross Margin is Increasing

55% > 58%

Low Operating Margin

Negative 3Y Average Operating Margin

-2%

Operating Margin is Increasing

-2% > 0%

Negative Net Margin

-12%

Negative 3Y Average Net Margin

-28%

Declining Net Margin

-5% > -12%

Negative Free Cash Flow Margin

-2%

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

6% > -2%

Negative ROE

-90%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2%

ROIC is Increasing

-1% > 1%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.